125 related articles for article (PubMed ID: 12552324)
21. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
22. Oxidized LDL inhibit hepatocyte growth factor synthesis in coronary smooth muscle cells.
Haug C; Lenz C; Bachem MG
Int J Cardiol; 2005 Sep; 103(3):298-306. PubMed ID: 16098393
[TBL] [Abstract][Full Text] [Related]
23. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer risk during HRT: influence of estradiol metabolites on breast cancer and endothelial cell proliferation.
Seeger H; Deuringer FU; Wallwiener D; Mueck AO
Maturitas; 2004 Nov; 49(3):235-40. PubMed ID: 15488352
[TBL] [Abstract][Full Text] [Related]
25. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
26. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial.
Kubista E; Planellas Gomez JV; Dowsett M; Foidart JM; Pohlodek K; Serreyn R; Nechushkin M; Manikhas AG; Semiglazov VF; Hageluken CC; Singer CF
Clin Cancer Res; 2007 Jul; 13(14):4185-90. PubMed ID: 17634547
[TBL] [Abstract][Full Text] [Related]
27. Tissue-selective effects of tibolone on the breast.
Kloosterboer HJ
Maturitas; 2004 Sep; 49(1):S5-S15. PubMed ID: 15351102
[TBL] [Abstract][Full Text] [Related]
28. Effects of cyclophilin A on cell proliferation and gene expressions in human vascular smooth muscle cells and endothelial cells.
Yang H; Li M; Chai H; Yan S; Lin P; Lumsden AB; Yao Q; Chen C
J Surg Res; 2005 Feb; 123(2):312-9. PubMed ID: 15680395
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
[TBL] [Abstract][Full Text] [Related]
30. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
[TBL] [Abstract][Full Text] [Related]
31. Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A.
Somjen D; Kohen F; Lieberherr M; Gayer B; Schejter E; Katzburg S; Limor R; Sharon O; Knoll E; Posner GH; Kaye AM; Stern N
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):293-303. PubMed ID: 15860273
[TBL] [Abstract][Full Text] [Related]
32. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
33. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
34. The need for tissue selective menopausal agents.
Eden J
Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
[TBL] [Abstract][Full Text] [Related]
35. Valsartan inhibits angiotensin II-stimulated proliferation of smooth muscle cells from human coronary artery.
Mueck AO; Seeger H; Lippert TH
Int J Clin Pharmacol Ther; 1999 Jul; 37(7):365-6. PubMed ID: 10442512
[TBL] [Abstract][Full Text] [Related]
36. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human breast cancer cell proliferation with estradiol metabolites is as effective as with tamoxifen.
Seeger H; Huober J; Wallwiener D; Mueck AO
Horm Metab Res; 2004 May; 36(5):277-80. PubMed ID: 15156405
[TBL] [Abstract][Full Text] [Related]
38. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice.
Desreux J; Kloosterboer H; Noël A; Frankenne F; Lemaire M; Putman M; Foidart JM
Gynecol Obstet Invest; 2007; 63(1):31-8. PubMed ID: 16899995
[TBL] [Abstract][Full Text] [Related]
39. Tissue-selectivity: the mechanism of action of tibolone.
Kloosterboer HJ
Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
[TBL] [Abstract][Full Text] [Related]
40. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
